Skip to main content
Equibles

STATE STREET CORP

Position in LYEL — Lyell Immunopharma, Inc.

CIK 93751 BOSTON, MA
Back to LYEL Full portfolio

Position in LYEL

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$2,603,774
+$1,148,983 QoQ
Shares Held
185,322
+155.5% QoQ
Ownership
0.756%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#14
of 87 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority Sole 30% Shared 0% None 70%

Common Shares in LYEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STATE STREET CORP holds $36,881,619,425 across 411 Biotechnology names. LYEL ranks #257 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 11,871,459 $5,896,909,829
2 REGN
Regeneron Pharmaceuticals, Inc.
 4,834,688 $3,014,621,355
3 INCY
Incyte Corp
 9,722,336 $1,102,124,008
4 MRNA
Moderna, Inc.
 15,726,193 $1,101,305,295
5 ALNY
Alnylam Pharmaceuticals, Inc.
 3,555,689 $1,070,369,059
6 RVMD
Revolution Medicines, Inc.
 4,897,051 $917,119,711
7 RPRX
Royalty Pharma plc
 12,338,229 $691,804,500
8 INSM
INSMED Inc
 6,052,174 $645,282,791

All Filings in LYEL

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,603,774 185,322
2026-03-31 $1,454,791 72,522
2025-12-31 $1,584,308 51,472
2025-09-30 $548,132 33,752
2025-06-30 $299,207 33,847
2025-03-31 $1,991,912 3,702,440
2024-12-31 $2,399,150 3,748,673
2024-09-30 $5,367,583 3,889,553
2024-06-30 $5,536,564 3,818,320
2024-03-31 $8,291,057 3,717,963
2023-12-31 $6,865,826 3,539,086
2023-09-30 $10,011,329 6,810,428
2023-06-30 $19,624,559 6,171,245
2023-03-31 $18,694,154 7,921,252
2022-12-31 $30,363,953 8,750,419
2022-09-30 $39,434,212 5,379,838
2022-06-30 $16,925,391 2,595,919
2022-03-31 $9,549,191 1,890,929
2021-12-31 $3,244,484 419,184
2021-09-30 $4,200,269 283,802